Response Inhibition Training for Children With Williams Syndrome
NCT ID: NCT02212314
Last Updated: 2017-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2014-05-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Animal-assisted Resilience Training for Children With Stressful Life Events or Autism Spectrum Disorder
NCT06025539
Cognitive Control and Metacognition Training
NCT06885684
Randomized Trial of Parent Training for Young Children With Autism
NCT01233414
Interpretive Biases in Children With Social Anxiety
NCT02219243
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
NCT01978210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Response Inhibition Training
Treatment group will receive immediate treatment after pre-test.
Response Inhibition Training
Computerized response inhibition training will be delivered via the Internet for 10 individual sessions.
Waitlist Crossover
Waitlist group will not receive intervention while treatment group is active, but waitlist group will be offered treatment after post-test is completed.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Response Inhibition Training
Computerized response inhibition training will be delivered via the Internet for 10 individual sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 10-17
* First language and main language spoken in the home is English
* Possess computer in the home that has internet access, and a second electronic device with access to Skype (e.g., smartphone, ipad, additional computer, ipod touch)
Exclusion Criteria
* No computer in the home with internet access (because the study is being conducted via the internet)
* Comorbid severe illnesses or major surgery within the past 6 months
* Four or more previous sessions of inhibition training
10 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Milwaukee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bonita P Klein-Tasman
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bonita P Klein-Tasman, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Milwaukee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin-Milwaukee Child Neurodevelopment Research Lab
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14.351
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.